110 related articles for article (PubMed ID: 16491127)
1. Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS.
Linghu H; Tsuda M; Makino Y; Sakai M; Watanabe T; Ichihara S; Sawa H; Nagashima K; Mochizuki N; Tanaka S
Oncogene; 2006 Jun; 25(25):3547-56. PubMed ID: 16491127
[TBL] [Abstract][Full Text] [Related]
2. Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex.
Payne SL; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2006 Jul; 98(4):827-37. PubMed ID: 16440329
[TBL] [Abstract][Full Text] [Related]
3. Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4.
Wang L; Tabu K; Kimura T; Tsuda M; Linghu H; Tanino M; Kaneko S; Nishihara H; Tanaka S
Biochem Biophys Res Commun; 2007 Nov; 362(4):976-81. PubMed ID: 17825249
[TBL] [Abstract][Full Text] [Related]
4. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
[TBL] [Abstract][Full Text] [Related]
5. Ankyrin repeat domain 28 (ANKRD28), a novel binding partner of DOCK180, promotes cell migration by regulating focal adhesion formation.
Tachibana M; Kiyokawa E; Hara S; Iemura S; Natsume T; Manabe T; Matsuda M
Exp Cell Res; 2009 Mar; 315(5):863-76. PubMed ID: 19118547
[TBL] [Abstract][Full Text] [Related]
6. CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cells.
Rodrigues SP; Fathers KE; Chan G; Zuo D; Halwani F; Meterissian S; Park M
Mol Cancer Res; 2005 Apr; 3(4):183-94. PubMed ID: 15831672
[TBL] [Abstract][Full Text] [Related]
7. Activation of Rac1 by RhoG regulates cell migration.
Katoh H; Hiramoto K; Negishi M
J Cell Sci; 2006 Jan; 119(Pt 1):56-65. PubMed ID: 16339170
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.
Crawford M; Brawner E; Batte K; Yu L; Hunter MG; Otterson GA; Nuovo G; Marsh CB; Nana-Sinkam SP
Biochem Biophys Res Commun; 2008 Sep; 373(4):607-12. PubMed ID: 18602365
[TBL] [Abstract][Full Text] [Related]
9. Proapoptotic function of the nuclear Crk II adaptor protein.
Kar B; Reichman CT; Singh S; O'Connor JP; Birge RB
Biochemistry; 2007 Sep; 46(38):10828-40. PubMed ID: 17764157
[TBL] [Abstract][Full Text] [Related]
10. The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3.
Wang H; Linghu H; Wang J; Che YL; Xiang TX; Tang WX; Yao ZW
Tumour Biol; 2010 Jan; 31(1):59-67. PubMed ID: 20237902
[TBL] [Abstract][Full Text] [Related]
11. Tumor promoting properties of the ETS protein MEF in ovarian cancer.
Yao JJ; Liu Y; Lacorazza HD; Soslow RA; Scandura JM; Nimer SD; Hedvat CV
Oncogene; 2007 Jun; 26(27):4032-7. PubMed ID: 17213815
[TBL] [Abstract][Full Text] [Related]
12. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.
Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H
Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241
[TBL] [Abstract][Full Text] [Related]
14. BAG3 regulates motility and adhesion of epithelial cancer cells.
Iwasaki M; Homma S; Hishiya A; Dolezal SJ; Reed JC; Takayama S
Cancer Res; 2007 Nov; 67(21):10252-9. PubMed ID: 17974966
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition.
Baba T; Kariya M; Higuchi T; Mandai M; Matsumura N; Kondoh E; Miyanishi M; Fukuhara K; Takakura K; Fujii S
Gynecol Oncol; 2007 Jun; 105(3):703-11. PubMed ID: 17376520
[TBL] [Abstract][Full Text] [Related]
16. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
[TBL] [Abstract][Full Text] [Related]
17. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
Noren NK; Foos G; Hauser CA; Pasquale EB
Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
[TBL] [Abstract][Full Text] [Related]
18. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase.
Hu XW; Meng D; Fang J
Carcinogenesis; 2008 Dec; 29(12):2369-76. PubMed ID: 18974065
[TBL] [Abstract][Full Text] [Related]
19. Identification of two signaling submodules within the CrkII/ELMO/Dock180 pathway regulating engulfment of apoptotic cells.
Tosello-Trampont AC; Kinchen JM; Brugnera E; Haney LB; Hengartner MO; Ravichandran KS
Cell Death Differ; 2007 May; 14(5):963-72. PubMed ID: 17304244
[TBL] [Abstract][Full Text] [Related]
20. ZRP-1 controls Rho GTPase-mediated actin reorganization by localizing at cell-matrix and cell-cell adhesions.
Bai CY; Ohsugi M; Abe Y; Yamamoto T
J Cell Sci; 2007 Aug; 120(Pt 16):2828-37. PubMed ID: 17652164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
